| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.0046 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |